Answers are grounded in this paper and cite their sources.
17β-N,N-Diethylcarbamoyl-4-methyl-4-aza-5αandrostan-3-one (4-MA) strongly inhibits the 5α-reductase-mediated conversion of testosterone (T) to 5α-dihydrotestosterone [17β-hydroxy-5α-androstan-3-one (DHT)] both in vitro and in vivo. In vitro, 4-MA is a more potent inhibitor than progesterone, androst-4-en-3-one-17β-carboxylic acid (17β), androst-4-en-3-one-17β-carboxylic acid methyl ester (17βME), megestrol acetate (17α-acetoxy-6-dehydro-6-methylprogesterone), medrogestone (6-methyl-6-dehydro-17-methylprogesterone), cyproterone acetate (17α-acetoxy-6-chloro-l,2α-methylene-4,5-pregnadiene-3,20-dione), or flutamide (4′-nitro-3′-trifluoromethylisobutyranilide). The effects of these compounds on prostatic concentrations of T and DHT were determined in young adult intact male rats treated 4 h before sacrifice. Subcutaneous injection of 0.33–10 mg 4-MAȯrat consistently reduced the prostatic concentrationof DHT but increased that of T. At 10 mg/rat, cyproterone acetate, megestrol acetate, and flutamide tended to reduce prostatic levels of both T and DHT, while progesterone, 17βC, 17βME, and medrogestone had little or no effect. Castrate male rats were pretreated with 1 or 10 mg 4-MA and, 2 h later, injected sc with either 200 μg testosterone propionate (TP) or 400 μg dihydrotestosterone propionate (DHTP). They were sacrificed 2 h after receiving exogenous androgen, and prostatic concentrations of T and DHT were determined. The 1-mg dose of 4-MA caused a marked reduction in the prostatic concentration of DHT in rats injected with TP but not in those given DHTP. These results were consistent with the view that 4-MA acts by inhibiting 5α-reductase. However, the 10-mg dose of 4-MA lowered the concentration of DHT in the prostates of animals which had received either TP or DHTP. This indicated that the higher dose of 4-MA may have reduced androgen uptake or retention, an effect not associated with 5α-reductase inhibition. Ventral prostate growth was attenuated by 4-MA in immature castrate male rats injected sc with either TP or T, but 4-MA had much less of an effect in rats given DHTP or DHT. These data further support the hypothesis that 4-MA antagonizes the androgenic action of T by interfering with its conversion to the more active metabolite, DHT.
No takes yet. Share an insight, caveat, or question.
Brooks et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: